MI
NVO

Markowski Investments’s Novo Nordisk NVO Stock Holding History

Markowski Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1K Buy
+899
New +$38.6K 0.01% 228

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Markowski Investments's NVO Position: Q2 2026 in Review

Markowski Investments opened a new position in Novo Nordisk (NVO) in Q2 2026: 899 shares worth $43.1K. The stake represents 0.01% of the portfolio and ranks #228 among its holdings.

1,132 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Markowski Investments held 899 shares of Novo Nordisk worth $43.1K as of Q2 2026.
  • Novo Nordisk was a new Markowski Investments position in Q2 2026.
  • Novo Nordisk made up 0.01% of Markowski Investments's portfolio in Q2 2026, its #228 holding.
  • 1,132 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.